ABCB11 and cholestasis: Second, in the treatment group, Bsep increased and Ntcp decreased, liver function damage was reduced, alanine aminotransferase and glutamic oxaloacetic aminotransferase were reduced, the bilirubin content was reduced, and the degree of cholestasis was improved.